Authors:
LESAGE AS
WOUTERS R
VANGOMPEL P
HEYLEN L
VANHOENACKER P
HAEGEMAN G
LUYTEN WHML
LEYSEN JE
Citation: As. Lesage et al., AGONISTIC PROPERTIES OF ALNIDITAN, SUMATRIPTAN AND DIHYDROERGOTAMINE ON HUMAN 5-HT1B AND 5-HT1D RECEPTORS EXPRESSED IN VARIOUS MAMMALIAN-CELL LINES, British Journal of Pharmacology, 123(8), 1998, pp. 1655-1665
Authors:
VANHOENACKER P
GOMMEREN W
LUYTEN WHML
LEYSEN JE
HAEGEMAN G
Citation: P. Vanhoenacker et al., STABLE, HIGH-LEVEL EXPRESSION OF HUMAN SEROTONIN RECEPTORS IN L929 CELLS USING AN INDUCIBLE EXPRESSION SYSTEM, Receptors & channels, 5(3-4), 1997, pp. 125-137
Authors:
LEYSEN JE
GOMMEREN W
HEYLEN L
LUYTEN WHML
VANDEWEYER I
VANHOENACKER P
HAEGEMAN G
SCHOTTE A
VANGOMPEL P
WOUTERS R
LESAGE AS
Citation: Je. Leysen et al., ALNIDITAN, A NEW 5-HYDROXYTRYPTAMINE(1D) AGONIST AND MIGRAINE-ABORTIVE AGENT - LIGAND-BINDING PROPERTIES OF HUMAN 5-HYDROXYTRYPTAMINE(1D-ALPHA), HUMAN 5-HYDROXYTRYPTAMINE(1D-BETA), AND CALF 5-HYDROXYTRYPTAMINE(1D) RECEPTORS INVESTIGATED WITH [H-3] 5-HYDROXYTRYPTAMINE AND [H-3] ALNIDITAN, Molecular pharmacology, 50(6), 1996, pp. 1567-1580
Authors:
DEBAKKER G
CROLLA D
VANHOENACKER P
BRIJS S
Citation: G. Debakker et al., EMBOLIZATION OF A CYSTIC LYMPHATIC MALFORMATION OF THE NECK, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 163(3), 1995, pp. 267-268
Citation: P. Vanhoenacker et al., STUDIES ON THE INDUCTION OF THE INTERLEUKIN-6 PROMOTER IN CELL LINES OF HUMAN AND SIMIAN ORIGIN, European cytokine network, 5(3), 1994, pp. 283-291
Authors:
VANHOENACKER P
BRIJS S
GEUSENS E
DEMAN R
DUJARDIN P
TANGHE W
Citation: P. Vanhoenacker et al., MR-IMAGING OF PRIMARY MUSCULAR SARCOIDOSIS - CASE-REPORT, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 161(6), 1994, pp. 570-571
Citation: P. Vanhoenacker et al., VENOUS STENTING WITH A SELF-EXPANDING PROSTHESIS IN SUPERIOR VENA-CAVA SYNDROME, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 160(2), 1994, pp. 178-180